Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7032612 | 0.87 | ALDH1A1 (0.63) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL11291855 | 0.86 | HTT (0.62) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL3297288 | 0.86 | XDH (0.57) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL11754281 | 0.86 | ALDH1A1 (0.74) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL11753742 | 0.86 | ALDH1A1 (0.67) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL21618379 | 0.81 | XDH (0.53) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL11404334 | 0.81 | XDH (1.00) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL8018399 | 0.80 | LMNA (0.67) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL8589797 | 0.80 | XDH (0.55) | XDHLMNAHTTMEN1KMT2A | |
| SCHEMBL15325683 | 0.78 | XDH (0.50) | XDHLMNAHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | claimed |
| EP-0070198-A1 | Radiation-sensitive composition and pattern-formation method using the same | Hitachi, Ltd. (JP) | 1983-01-19 | — | — | EP | claimed |
| US-12636379-B2 | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | Sonotarg Limited (GB) | 2026-05-26 | — | — | US | disclosed |
| CN-119823106-A | Enhanced nucleic acid polymerization by aromatic compounds | 豪夫迈·罗氏有限公司 | 2025-04-15 | — | — | CN | disclosed |
| WO-2025034034-A1 | NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER OR TUMORS COMPRISING SAME | 주식회사 대웅제약 | 2025-02-13 | — | — | WO | disclosed |
| CN-114144520-B | Enhanced nucleic acid polymerization by aromatic compounds | 豪夫迈·罗氏有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-111771001-B | Enhanced nucleic acid polymerization by aromatic compounds | F·霍夫曼-罗氏股份公司 | 2024-09-06 | — | — | CN | disclosed |
| US-11970731-B2 | Enhancement of nucleic acid polymerization by aromatic compounds | Roche Sequencing Solutions, Inc. (US) | 2024-04-30 | — | — | US | disclosed |
| EP-3735409-B1 | ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS | STRATOS GENOMICS INC (US) | 2023-06-21 | — | — | EP | disclosed |
| US-20220347314-A1 | MICROBUBBLE-CHEMOTHERAPEUTIC AGENT COMPLEX FOR SONODYNAMIC THERAPY | UNIVERSITY OF ULSTER (GB) | 2022-11-03 | — | — | US | disclosed |
| US-11382987-B2 | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | UNIVERSITY OF ULSTER (GB) | 2022-07-12 | — | — | US | disclosed |
| WO-1989001160-A1 | NEW BIFUNCTIONAL PHOTOEXCITABLE REAGENTS, THEIR PREPARATION AND USE, IN PARTICULAR FOR PHOTOAFFINITY LABELLING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 1989-02-09 | — | — | WO | disclosed |
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | disclosed |
| EP-0118093-A1 | Trichloroacryloyl urea derivatives, process for their preparation and their use as fungicides in agriculture and horticulture | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1984-09-12 | — | — | EP | disclosed |
| US-4465768-A | Pattern-formation method with iodine containing azide and oxygen plasma etching of substrate | HITACHI, LTD. (JP) | 1984-08-14 | — | — | US | disclosed |
| US-4411912-A | Insecticidal isovaleric acid esters | ZOECON CORPORATION (US) | 1983-10-25 | — | — | US | disclosed |
| EP-0070198-A1 | Radiation-sensitive composition and pattern-formation method using the same | Hitachi, Ltd. (JP) | 1983-01-19 | — | — | EP | disclosed |
| US-4243819-A | Substituted amino acids | ZOECON CORPORATION (US) | 1981-01-06 | — | — | US | disclosed |
| US-4053527-A | REACTING HALONITROANILINES WITH ALCOHOLS AND NITROSATING AGENTS ION | BASF AKTIENGESELLSCHAFT (DT) | 1977-10-11 | — | — | US | disclosed |
| US-3978040-A | Process for the preparation of cyanoazo compounds by reacting halogenoazo compounds with CuCN in an aqueous media in the presence of a nitrogen base | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636379-B2 | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | SON, BID, BCL2 | XDH 2182/4885LMNA 1973/4885HTT 1297/4885 |
| US-20220347314-A1 | MICROBUBBLE-CHEMOTHERAPEUTIC AGENT COMPLEX FOR SONODYNAMIC THERAPY | SON, RNASE1, ANXA5 | XDH 4495/4885LMNA 2250/4885HTT 2374/4885 |
| US-11382987-B2 | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | SON, RNASE1, ANXA5 | XDH 4495/4885LMNA 2250/4885HTT 2374/4885 |
| US-11970731-B2 | Enhancement of nucleic acid polymerization by aromatic compounds | POLN, POLB, POLRMT | XDH 1496/4885LMNA 321/4885HTT 145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.